These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16368452)

  • 1. Controlled-release oxycodone-induced seizures.
    Klein M; Rudich Z; Gurevich B; Lifshitz M; Brill S; Lottan M; Weksler N
    Clin Ther; 2005 Nov; 27(11):1815-8. PubMed ID: 16368452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study.
    Portenoy RK; Farrar JT; Backonja MM; Cleeland CS; Yang K; Friedman M; Colucci SV; Richards P
    Clin J Pain; 2007 May; 23(4):287-99. PubMed ID: 17449988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled release oxycodone--a new option in the treatment of severe and very severe pain. Review of studies on neuropathic, physical activity-related and postoperative pain].
    Stiehl M
    MMW Fortschr Med; 2004 Aug; 146 Suppl 2():61-9. PubMed ID: 16739361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-controlled analgesia versus oral controlled-release oxycodone - are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries?
    Ho HS
    Oncology; 2008; 74 Suppl 1():61-5. PubMed ID: 18758200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients.
    Ma K; Jiang W; Zhou Q; Du DP
    Int J Clin Pract; 2008 Feb; 62(2):241-7. PubMed ID: 18070045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.
    Suzuki T; Morishita M; Ito E; Matsuura M; Tanaka R; Saito T
    Am J Ther; 2008; 15(1):31-5. PubMed ID: 18223351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients.
    Gaertner J; Radbruch L; Giesecke T; Gerbershagen H; Petzke F; Ostgathe C; Elsner F; Sabatowski R
    Acta Anaesthesiol Scand; 2006 Jul; 50(6):664-72. PubMed ID: 16987359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of oxycodone in polytrauma patients: the "Gemelli" experience.
    Franceschi F; Marini M; Ursella S; Carbone L; Candelli M; Pignataro G; Gabrielli M; Santarelli L; Ojetti V; Giupponi B; Fiore V; Barbaro F; De Marco G; Buccelletti F; Mancini F; Roccarina D; Gigante G; Gasbarrini A; Gasbarrini G; Silveri NG
    Eur Rev Med Pharmacol Sci; 2008; 12(2):123-6. PubMed ID: 18575163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain.
    Gallagher RM; Welz-Bosna M; Gammaitoni A
    Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy.
    Blumenthal S; Min K; Marquardt M; Borgeat A
    Anesth Analg; 2007 Jul; 105(1):233-7. PubMed ID: 17578980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR; Moore J; Gray RO; Skinner L; Biros MH
    Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probable codeine phosphate-induced seizures.
    Kuo SC; Lin YC; Kao SM; Yang YH
    Ann Pharmacother; 2004 Nov; 38(11):1848-51. PubMed ID: 15466903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conversion ratio between intravenous oxycodone/hydrocotarnine and sustained-release oral oxycodone in patients with cancer pain].
    Kokubun H; Nakamura K; Fukawa M; Matoba M; Hoka S; Yago K
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2255-8. PubMed ID: 18079625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.